NanoAlum based delivery system to formulate in-situ vaccine for personalized breast cancer immunotherapy-百迪生物科技

首页 > 文献支持 > NanoAlum based delivery system to formulate in-situ vaccine for personalized breast cancer immunotherapy

NanoAlum based delivery system to formulate in-situ vaccine for personalized breast cancer immunotherapy

2025-06-10·文献支持

加入收藏去分享

发布日期： 2025-06-10

来源：

作者： Ying Li, Jingsong Lu, Xiaohan Gao, Sumei Chen, Abdul Fahad, Neema Pambe, Wensheng Xie, Zhenhu Guo, Yen Wei, Lingyun Zhao

加入收藏去分享

来源网址：https://www.sciopen.com/article/10.26599/NR.2025.94907642

期刊：Nano Research丨丨引用百迪产品：A300-500 胰酶（胰蛋白酶 0.25%，EDTA 0.02%)

IF：9.5

上一篇

日期：2025-06-12

Exercise Mimetic Exosomes Re-establish the Extracellular Matrix Metabolic Balance and Alleviate the Inflammatory Macrophage Infiltration in Intervertebral Disc Degeneration

下一篇

日期：2025-06-09

GJB2 enhances cancer stem cell properties by modulating SOX2 expression via NF-κB pathway activation in lung adenocarcinoma

400-601-2023

service@biocode.cn

浙江省杭州市余杭区良渚生命科技小镇5号楼4楼（公司总部）

百迪科技所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务 CopyRight © 2023 浙江百迪生物科技有限公司 All Rights Reserved. 浙ICP备2022012557号-2

网站技术支持：宽尔科技